The State of Cancer Care in America, 2015: A report by the American Society of Clinical Oncology

Journal of Oncology Practice

Volumn 11, Issue 2, 2015, Pages 79-113

  Kirkwood, M Kelsey ^a  

^a AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTRONIC CIGARETTE;

ARTICLE; CANCER SURVIVAL; CANCER SURVIVOR; ETHNIC DIFFERENCE; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HUMAN; MEDICAL PRACTICE; MEDICAL SOCIETY; OBESITY; ONCOLOGY; PATIENT CARE; PUBLIC HEALTH; UNITED STATES; MANPOWER; NEOPLASMS;

HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; QUALITY OF HEALTH CARE; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84925325688     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2015.003772     Document Type: Article

References (165)

1. American Cancer Society: Cancer treatment and survivorship: Facts and figures 2014-2015. http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-042801.pdf
2. US Food and Drug Administration: Hematology/oncology (cancer) approvals and safety notifications. http://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm279174.htm
3. Pharmaceutical Research and Manufacturers of America: Drugs in development: Cancer. http://www.phrma.org/sites/default/files/pdf/2014-cancer-report.pdf
4. Blumenthal D, Collins SR: Health care coverage under the Affordable Care Act: A progress report. N Engl J Med 371:275-281, 2014
5. National Cancer Institute: Obesity and cancer risk. http://www.cancer.gov/cancertopics/factsheet/risk/obesity
6. Polednak AP: Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer Detect Prev 32:190-199, 2008
7. Wang YC, McPherson K, Marsh T, et al: Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378:815-825, 2011
8. Dutra LM, Glantz SA: Electronic cigarettes and conventional cigarette use among U.S. adolescents: A cross-sectional study. JAMA Pediatr 168:610-617, 2014
9. Centers for Medicare and Medicaid Services: Official Physician Compare data. https://data.medicare.gov/data/physician-compare
10. American Medical Association: AMA Physician Masterfile. http://www.amaassn.org/ama/pub/about-ama/physician-data-resources/physician-masterfile.page
11. Brotherton SE, Etzel SI: Graduate medical education, 2013-2014. JAMA 312:2427-2445, 2014
12. US Census Bureau: 2010 Census urban area facts. https://www.census.gov/geo/reference/ua/uafacts.html
13. Onega T, Duell EJ, Shi X, et al: Geographic access to cancer care in the U.S. Cancer 112:909-918, 2008
14. Ward MM, Ullrich F, Matthews K, et al: Access to chemotherapy services by availability of local and visiting oncologists. J Oncol Pract 10:26-31, 2014
15. US Census Bureau: TIGER/Line Shapefiles and TIGER/Line Files. https://www.census.gov/geo/maps-data/data/tiger-line.html
16. Gruca TS, Nam I, Tracy R: Trends in medical oncology outreach clinics in rural areas. J Oncol Pract 10:e313-e320, 2014
17. Chandak AN, Loberiza FR Jr, Deras M, et al: Estimating the state-level supply of cancer care providers: Preparing to meet workforce needs in the wake of health care reform. J Oncol Pract [epub ahead of print on November 12, 2014]
18. Shanafelt TD, Raymond M, Horn L, et al: Oncology fellows' career plans, expectations, and well-being: Do fellows know what they are getting into? J Clin Oncol 32:2991-2997, 2014
19. Mulcahy AW, Armstrong C, Lewis J, et al: The 340B Prescription Drug Discount Program: Origins, implementations, and post-reform future. http://www.rand.org/pubs/perspectives/PE121.html
20. Conti RM, Bach PB: The 340B Drug Discount Program: Hospitals generate profits by expanding to reach more affluent communities. Health Aff (Millwood) 33:1786-1792, 2014
21. Alliance for Integrity and Reform of 340B: Unfulfilled expectations: An analysis of charity care provided by 340B hospitals. http://340breform.org/userfiles/Final%20AIR%20340B%20Charity%20Care%20Paper.pdf
22. IMS Institute: Innovation in cancer care and implications for health systems: Global oncology trend report. http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/IMS%20Health%20Institute/Reports/Secure/IMSH-Oncology-Trend-Report.pdf
23. Smith BD, Smith GL, Hurria A, et al: Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol 27:2758-2765, 2009
24. Friends of Cancer Research: Breakthrough therapies. http://www.focr.org/breakthrough-therapies
25. MyCancer Genome: Overview of targeted therapies for cancer. http://www.mycancergenome.org/content/other/molecular-medicine/overview-of-targeted-therapies-forcancer/
26. US Food and Drug Administration: Frequently asked questions: Breakthrough therapies. http://www.fda.gov/regulatoryinformation/legislation/federalfooddrugandcosmeticactfdcact/significantamendmentstothefdcact/fdasia/ucm341027.htm
27. US Food and Drug Administration: 2014 device approvals. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm381097.htm
28. US Food and Drug Administration: FDA approves first non-invasive DNA screening test for colorectal cancer. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm409021.htm
29. US Food and Drug Administration: Evaluation of automatic class III designation (de novo) summaries. http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHTransparency/ucm232269.htm
30. Collins FS, Hamburg MA: First FDA authorization for next-generation sequencer. N Engl J Med 369:2369-2371, 2013
31. Howlader N, Noone AM, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2011. http://seer.cancer.gov/csr/1975-2011/
32. American Cancer Society: Cancer facts and figures 2014. http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf
33. Ma J, Siegel R, Jemal A: Pancreatic cancer death rates by race among US men and women, 1970-2009. J Natl Cancer Inst 105:1694-1700, 2013
34. Altekruse SF, Henley SJ, Cucinelli JE, et al: Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol 109:542-553, 2014
35. Congressional Budget Office: Insurance coverage provisions of the Affordable Care Act: CBO's April 2014 baseline. https://www.cbo.gov/sites/default/files/cbofiles/attachments/43900-2014-04-ACAtables2.pdf
36. Yang W, Williams JH, Hogan PF, et al: Projected supply of and demand for oncologists and radiation oncologists through 2025: An aging, better-insured population will result in shortage. J Oncol Pract 10:39-45, 2014
37. West LA, Cole S, Goodkind D, et al: 65+ in the United States: 2010. http://www.census.gov/content/dam/Census/library/publications/2014/demo/p23-212.pdf
38. Hudson SV, Miller SM, Hemler J, et al: Adult cancer survivors discuss follow-up in primary care: "Not what I want, but maybe what I need." Ann Fam Med 10:418-427, 2012
39. Smith JK, Ng SC, Zhou Z, et al: Does increasing insurance improve outcomes for US cancer patients? J Surg Res 185:15-20, 2013
40. Mueller EL, Park ER, Davis MM: What the Affordable Care Act means for survivors of pediatric cancer. J Clin Oncol 32:615-617, 2014
41. The Advisory Board Company: Where the states stand on Medicaid expansion. http://www.advisory.com/daily-briefing/resources/primers/medicaidmap#lightbox/1/
42. Polite BN, Griggs JJ, Moy B, et al: American Society of Clinical Oncology policy statement on Medicaid reform. 32:4162-4167, 2014
43. Levitt L, Claxton G, Damico A: The numbers behind "young invincibles" and the Affordable Care Act. http://kff.org/health-reform/perspective/the-numbers-behind-young-invincibles-and-the-affordable-care-act/
44. Aizer AA, Falit B, Mendu ML, et al: Cancer-specific outcomes among young adults without health insurance. J Clin Oncol 32:2025-2030, 2014
45. Kasperkevic J: Millennials on Obamacare: What do you mean, affordable? http://www.theguardian.com/money/2014/apr/06/millennials-obamacare-insurance-cost-health-invincible
46. Centers for Medicare and Medicaid Services: Additional information on proposed state essential health benefits benchmark plans. http://www.cms.gov/CCIIO/Resources/Data-Resources/ehb.html
47. Robinson SW, Brantley K, Liow C, et al: An early examination of access to select orphan drugs treating rare diseases in health insurance exchange plans. J Manag Care Pharm 20:997-1004, 2014
48. Jost TS: Implementing health reform: Four years later. Health Aff (Millwood) 33:7-10, 2014
49. Centers for Medicare and Medicaid Services: 2015 letter to issuers in the federally-facilitated marketplaces. http://www.cms.gov/CCIIO/Resources/Regulations-and-Guidance/Downloads/2015-final-issuer-letter-3-14-2014.pdf
50. National Cancer Institute: SEER stat fact sheets: All cancer sites. http://seer.cancer.gov/statfacts/html/all.html
51. Ogden CL, Carroll MD, Kit BK, et al: Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 311:806-814, 2014
52. Fryar CD, Carroll MD, Ogden CL: Prevalence of overweight, obesity, and extreme obesity among adults: United States, 1960-1962 Through 2007-2008. http://www.cdc.gov/nchs/data/hestat/obesity-adult-11-12/obesity-adult-11-12.htm
53. Centers for Disease Control and Prevention: CDC Grand Rounds: Childhood obesity in the United States. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6002a2.htm
54. Parekh N, Chandran U, Bandera EV: Obesity in cancer survival. Annu Rev Nutr 32:311-342, 2012
55. Calle EE, Rodriguez C, Walker-Thurmond K, et al: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638, 2003
56. US Food and Drug Administration: FDA proposes to extend its tobacco authority to additional tobacco products, including e-cigarettes. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm394667.htm
57. American Society of Clinical Oncology: ASCO, AACR urge FDA to regulate all tobacco products: Including e-cigarettes. http://www.asco.org/advocacy/asco-aacr-urge-fda-regulate-all-tobacco-products%E2%80%94including-e-cigarettes
58. Kirkwood MK, Kosty MP, Bajorin DF, et al: Tracking the workforce: The American Society of Clinical Oncology workforce information system. J Oncol Pract 9:3-8, 2013
59. American Association of Nurse Practitioners: State practice environment. http://www.aanp.org/legislation-regulation/state-legislation-regulation/state-practiceenvironment/66-legislation-regulation/state-practice-environment/1380-state-practice-by-type
60. American Assciation of Nurse Practitioners: NP fact sheet. http://www.aanp.org/all-about-nps/np-fact-sheet
61. American Academy of Physician Assistants: 2013 AAPA annual survey report. http://www.aapa.org/WorkArea/DownloadAsset.aspx?id=2902
62. American Academy of Physician Assistants: Physician assistant census report: Results from the 2010 AAPA Census. http://www.aapa.org/workarea/downloadasset.aspx?id=1454
63. US Bureau of Labor Statistics: Employment by detailed occupation. http://www.bls.gov/emp/ep-table-102.htm
64. Association of American Medical Colleges: Diversity in the physician workforce: Facts and figures 2014. http://aamcdiversityfactsandfigures.org/
65. US Census Bureau: State and county quick facts. http://quickfacts.census-.gov/qfd/states/00000.html
66. American Society of Clinical Oncology: Medical Oncology In-Training Examination. http://www.asco.org/professional-development/medical-oncology-training-examination
67. National Rural Health Association: What's different about rural health care? http://www.ruralhealthweb.org/go/left/about-rural-health/what-s-different-about-rural-healthcare
68. Chen C, Petterson S, Phillips RL, et al: Toward graduate medical education (GME) accountability: Measuring the outcomes of GME institutions. Acad Med 88:1267-1280, 2013
69. American Society of Clinical Oncology: The state of cancer care in America, 2014: A report by the American Society of Clinical Oncology. J Oncol Pract 10:119-142, 2014
70. Shanafelt TD, Gradishar WJ, Kosty M, et al: Burnout and career satisfaction among US oncologists. J Clin Oncol 32:678-686, 2014
71. Sadic B: Physician burnout is on the rise. http://www.chicagotribune.com/lifestyles/health/sc-health-1015-physician-burnout-2-20141014-story.html#page=1
72. Towle EL, Barr TR, Senese JL: The National Practice Benchmark for oncology, 2014 report on 2013 data. J Oncol Pract 10:385-406, 2014
73. Barr P: The boomer challenge. http://www.hhnmag.com/display/HHN-newsarticle.dhtml?dcrPath=/templatedata/HF-Common/NewsArticle/data/HHN/Magazine/2014/Jan/cover-story-baby-boomers
74. Kolata G: Private oncologists being forced out, leaving patients to face higher bills. http://www.nytimes.com/2014/11/24/health/private-oncologists-being-forced-out-leaving-patients-to-face-higher-bills.html?-r=0
75. Heisy-Grove D, Patel V: Physician motivations for adoption of electronic health records. http://www.healthit.gov/sites/default/files/oncdatabrief-physician-ehr-adoption-motivators-2014.pdf
76. O'Rourke KM: EHRs not living up to the hype. http://www.medscape.com/viewarticle/833224
77. Centers for Medicare and Medicaid Services: The official Web site for the Medicare and Medicaid Electronic Health Records (EHR) Incentive Programs. http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/index.html?redirect=/ehrincentiveprograms/
78. Centers for Medicare and Medicaid Services: Preauthorization. https://www.healthcare.gov/glossary/preauthorization/
79. Cohn J: The robot will see you. http://www.theatlantic.com/magazine/archive/2013/03/the-robot-will-see-you-now/309216/
80. US Food and Drug Administration: Report to Congress: First annual report on drug shortages for calendar year 2013. http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM384892.pdf
81. US Government Accountability Office: Drug shortages: Public health threat continues, despite efforts to help ensure product availability. http://www.gao.gov/assets/670/660785.pdf
82. The White House: Executive Order 13588: Reducing prescription drug shortages. http://www.whitehouse.gov/the-press-office/2011/10/31/executive-order-reducing-prescription-drug-shortages
83. US Food and Drug Administration: Fact sheet: Drug products in shortage in the United States. http://www.fda.gov/RegulatoryInformation/Legislation/FederalFood-DrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDASIA/ucm313121.htm
84. National Institute for Occupational Safety and Health: Preventing occupational exposure to antineoplastic and other hazardous drugs in healthcare settings. http://www.cdc.gov/niosh/docs/2004-165/
85. American Society of Clinical Oncology: Comments on proposed USP General Chapter. http://www.asco.org/sites/www.asco.org/files/asco-usp-800-comments-final-cc.pdf
86. US Pharmacopeial Convention: Proposed General Chapter hazardous drugs: Handling in healthcare setting. http://www.usp.org/usp-nf/notices/general-chapter-hazardous-drugs-handling-healthcare-settings
87. US Government Accountability Office: Drug pricing: Manufacturer discounts in the 340B program offer benefits, but federal oversight needs improvement. http://www.gao.gov/assets/330/323702.pdf
88. House of Representatives Energy and Commerce Committee: House Report Number 102-384 (II), 1992
89. Office of Inspector General Department of Health and Human Services: Contract pharmacy arrangements in the 340B program, OEI-05-13-00431. https://oig.hhs.gov/oei/reports/oei-05-13-00431.pdf
90. Elson E, Shankar A: Recent court decision may impact 340B Drug Pricing Program "mega-reg." http://www.healthcarelawtoday.com/2014/06/23/recent-court-decision-may-impact-340b-drug-pricing-program-mega-reg/
91. Lee J: HHS 340B drug discount program holds off on "mega-reg." http://www.modernhealthcare.com/article/20141114/NEWS/311149966
92. American Society of Clinical Oncology: Policy statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology. J Oncol Pract 10:259-263, 2014
93. Davis K, Stremikis K, Schoen C, et al: Mirror, mirror on the wall, 2014 update: How the U.S. health care system compares internationally. http://www.commonwealthfund.org/publications/fund-reports/2014/jun/mirror-mirror
94. Organization for Economic Cooperation and Development: Health at a glance 2013: OECD indicators. http://www.oecd.org/els/health-systems/Health-at-a-Glance-2013.pdf
95. Hassett MJ, Neville BA, Weeks JC: The relationship between quality, spending and outcomes among women with breast cancer. J Natl Cancer Inst 106, 2014
96. Mariotto AB, Yabroff KR, Shao Y, et al: Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 103:117-128, 2011
97. Ramsey S, Blough D, Kirchhoff A, et al: Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) 32:1143-1152, 2013
98. Dusetzina SB, Winn AN, Abel GA, et al: Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol 32:306-311, 2014
99. Zafar SY, McNeil RB, Thomas CM, et al: Population-based assessment of cancer survivors' financial burden and quality of life: A prospective cohort study. J Oncol Pract 11:145-150, 2015
100. Ubel PA, Abernethy AP, Zafar SY: Full disclosure: Out-of-pocket costs as side effects. N Engl J Med 369:1484-1486, 2013
101. Smith SK, Nicolla J, Zafar SY: Bridging the gap between financial distress and available resources for patients with cancer: A qualitative study. J Oncol Pract 10:e368-e372, 2014
102. Khera N: Reporting and grading financial toxicity. J Clin Oncol 32:3337-3338, 2014
103. Memorial Sloan Kettering Cancer Center: Cost of cancer drugs. http://www.mskcc.org/research/health-policy-outcomes/cost-drugs
104. The Moran Company: Cost differences in cancer care across settings. http://www.communityoncology.org/UserFiles/Moran-Cost-Site-Differences-Study-P2.pdf
105. EvaluatePharma: Budget Busters: The shift to high-priced innovator drugs in the USA. http://www.evaluategroup.com/public/Reports/EvaluatePharma-Budget-Busters-the-Shift-to-High-Priced-Innovator-Drugs.aspx
106. Kantarjian HM, Fojo T, Mathisen M, et al: Cancer drugs in the United States: Justum pretium-The just price. J Clin Oncol 31:3600-3604, 2013
107. Hirsch BR, Balu S, Schulman KA: The impact of specialty pharmaceuticals as drivers of health care costs. Health Aff (Millwood) 33:1714-1720, 2014
108. Conti RM, Fein AJ, Bhatta SS: National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011. Health Aff (Millwood) 33:1721-1727, 2014
109. Kantarjian H, O'Brien S: The Chronic Leukemias. Philadelphia, PA, Elsevier Saunders, 2012
110. Robinson JC, Howell S: Specialty pharmaceuticals: Policy initiatives to improve assessment, pricing, prescription, and use. Health Aff (Millwood) 33:1745-1750, 2014
111. Siddiqui M, Rajkumar SV: The high cost of cancer drugs and what we can do about it. Mayo Clin Proc 87:935-943, 2012
112. Newcomer LN: Innovative payment models and measurement for cancer therapy. J Oncol Pract 10:187-189, 2014
113. Anhang Price R, Stranges E, Elixhauser A: Cancer hospitalizations for adults, 2009. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb125.jsp
114. Brooks GA, Abrams TA, Meyerhardt JA, et al: Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol 32:496-503, 2014
115. National Academy of Sciences: Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Washington, DC, National Academies Press, 2013
116. Ayanian JZ, Zaslavsky AM, Guadagnoli E, et al: Patients' perceptions of quality of care for colorectal cancer by race, ethnicity, and language. J Clin Oncol 23:6576-6586, 2005
117. Aubin M, Giguère A, Martin M, et al: Interventions to improve continuity of care in the follow-up of patients with cancer. Cochrane Database Syst Rev 7:CD007672, 2012
118. Press MJ: Instant replay: A quarterback's view of care coordination. N Engl J Med 371:489-491, 2014
119. Medicare Payment Advisory Commission: Report to the Congress: Medicare and the health care delivery system. http://www.medpac.gov/documents/congressionaltestimony/testimony-report-to-the-congress-medicare-and-the-health-care-delivery-system-(ways-and-means-june-18-2014).pdf?sfvrsn=0
120. th United States Congress (ed 2), 2014
121. Appleby J: Insurers push back against growing cost of cancer treatments. http://kaiserhealthnews.org/news/insurers-push-against-cancer-treatment-cost/
122. Kreys ED, Koeller JM: Documenting the benefits and cost savings of a large multistate cancer pathway program from a payer's perspective. J Oncol Pract 9:e241-e247, 2013
123. Kreys ED, Kim TY, Delgado A, et al: Impact of cancer supportive care pathways compliance on emergency department visits and hospitalizations. J Oncol Pract 10:168-173, 2014
124. Kuznar W: Variations in cancer treatment raise average cost of care by $25,000 per patient. http://www.ahdbonline.com/issues/2013/august-2013-vol-6-no-6-specialissue/1497-article-1497
125. Hoverman JR, Klein I, Harrison DW, et al: Opening the black box: The impact of an oncology management program consisting of level I pathways and an outbound nurse call system. J Oncol Pract 10:63-67, 2014
126. Mathews AW: Insurers push to rein in spending on cancer care. http://www.wsj.com/articles/insurer-to-reward-cancer-doctors-for-adhering-to-regimens-1401220033
127. Institute of Medicine: National Cancer Policy Forum Workshop: Policy issues in the development and adoption of molecularly targeted therapies for cancer. http://www.iom.edu/Activities/Disease/NCPF/2014-NOV-10.aspx
128. Cancer Support Community: Statement on decision-making in cancer care. http://www.cancersupportcommunity.org/General-Documents-Category/Policy/Statement-on-Decision-Making-in-Cancer-Care.pdf
129. Hartzband P, Groopman J: How Medical Care Is Being Corrupted. http://www.nytimes.com/2014/11/19/opinion/how-medical-care-is-being-corrupted.html?-r=0
130. Centers for Medicare and Medicaid Services: Specialty practitioner payment model opportunities: General information. http://innovation.cms.gov/initiatives/Specialty-Practitioner/
131. Ridgely MS, de Vries D, Bozic KJ, et al: Bundled payment fails to gain a foothold in California: The experience of the IHA bundled payment demonstration. Health Aff (Millwood) 33:1345-1352, 2014
132. National Institute for Health Care Management: Bundled payments for oncology: Creating value-based episodes of care. http://www.nihcm.org/bundled-payments-for-oncology-creating-value-based-episodes-of-care
133. Newcomer LN, Gould B, Page RD, et al: Changing physician incentives for affordable, quality cancer care: Results of an episode payment model. J Oncol Pract 10:322-326, 2014
134. The Commonwealth Fund: Guiding transformation: How medical practices can become patient-centered medical homes. http://www.commonwealthfund.org/~/media/Files/Publications/Fund%20Report/2012/Feb/1582-Wagner-guiding-transformation-patientcentered-med-home-v2.pdf
135. Centers for Medicare and Medicaid Services: Health Care Innovation Awards round one project profiles. http://innovation.cms.gov/files/x/hcia-projectprofiles.pdf
136. Centers for Medicare and Medicaid Services: Health Care Innovation Awards round two project profiles. http://innovation.cms.gov/Files/x/HCIATwoPrjProCombined.pdf
137. Centers for Medicare and Medicaid Services: Preliminary design for an oncology-focused model. http://www.asco.org/sites/www.asco.org/files/cms-innovation-center-oncology-model-preliminary-design-paper-0.pdf
138. Community Oncology Alliance: Oncology medical home: Improved quality and cost of care. http://coaadvocacy.org/2014/09/oncology-medical-home-improved-quality-and-cost-of-care/
139. Oncology Medical Home: Commission on Cancer accreditation. http://www.medicalhomeoncology.org/coa/commission-on-cancer-accreditation.htm
140. Patient-Centered Outcomes Research Institute: Research and results. http://www.pcori.org/research-results
141. Agency for Healthcare Research and Quality: Community-based oncology practice redesigns processes based on patient-centered medical home model to enhance access, improve quality, and reduce costs. https://innovations.ahrq.gov/profiles/community-based-oncology-practice-redesigns-processes-based-patient-centered-medical-home
142. Kuntz G, Tozer JM, Snegosky J, et al: Michigan Oncology Medical Home Demonstration Project: First-year results. J Oncol Pract 10:294-297, 2014
143. Patient-Centered Outcomes Research Institute: Evaluating the impact of patient-centered oncology care. http://www.pcori.org/research-results/2013/evaluating-impact-patient-centered-oncology-care
144. National Committee for Quality Assurance: Patient-centered specialty practice recognition. http://www.ncqa.org/Programs/Recognition/Practices/PatientCenteredSpecialtyPracticePCSP.aspx
145. Robeznieks A: At home with the specialist: Oncologists and other specialists launching patient-centered medical homes. Mod Healthc 44:22,24-25, 2014
146. Centers for Medicare and Medicaid Services: Medicare provider utilization and payment data: Physician and other supplier. http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/Physician-and-Other-Supplier.html
147. Whoriskey P, Keating D, Sun LH: Data uncover nation's top Medicare billers. http://www.washingtonpost.com/business/economy/data-uncover-nations-top-medicarebillers/2014/04/08/9101a77e-bf39-11e3-b574-f8748871856a-story.html
148. Centers for Medicare and Medicaid Services: Group practice reporting option. http://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/PQRS/Group-Practice-Reporting-Option.html
149. Trebes N: Providers can now use QOPI for Medicare PQRS reporting. http://www.advisory.com/research/oncology-roundtable/oncology-rounds/2014/12/providers-can-now-use-qopi-for-medicare-pqrs-reporting
150. Basch E, Snyder C, McNiff K, et al: Patient-reported outcome performance measures in oncology. J Oncol Pract 10:209-211, 2014
151. Bull JH, Abernethy AP: Expanding use of palliative care in the oncology setting. N C Med J 75:274-278, 2014
152. Teno JM, Gozalo PL: Quality and costs of end-of-life care: The need for transparency and accountability. JAMA 312:1868-1869, 2014
153. Parikh RB, Kirch RA, Smith TJ, et al: Early specialty palliative care: Translating data in oncology into practice. N Engl J Med 369:2347-2351, 2013
154. Von Roenn JH, Temel J: The integration of palliative care and oncology: The evidence. Oncology (Williston Park) 25:1258-1260, 2011
155. Temel JS, Greer JA, Muzikansky A, et al: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733-742, 2010
156. Obermeyer Z, Makar M, Abujaber S, et al: Association between the medicare hospice benefit and health care utilization and costs for patients with poorprognosis cancer. JAMA 312:1888-1896, 2014
157. Kamal AH, Gradison M, Maguire JM, et al: Quality measures for palliative care in patients with cancer: A systematic review. J Oncol Pract 10:281-287, 2014
158. Greco MT, Roberto A, Corli O, et al: Quality of cancer pain management: An update of a systematic review of undertreatment of patients with cancer. J Clin Oncol 32:4149-4154, 2014
159. Hui D, Kim SH, Roquemore J, et al: Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer 120:1743-1749, 2014
160. Project Data Sphere: Project Data Sphere initiative. https://projectdatasphere.org/projectdatasphere/html/home.html
161. Centers for Disease Control and Prevention: Comparative Effectiveness Research Data Collection Enhancement Project. http://www.cdc.gov/cancer/npcr/cer-data-collection.htm
162. Mini-Sentinel: Welcome to Mini-Sentinel. http://mini-sentinel.org/
163. US Department of Health and Human Services: Medicaid and CHIP enrollment grows by 8.7 million additional Americans. http://www.hhs.gov/healthcare/facts/blog/2014/10/medicaid-chip-enrollment-august.html#-ftn1
164. American Society of Clinical Oncology: Quality cancer care out of reach for millions of Americans. http://www.asco.org/sites/www.asco.org/files/medicaid-infographic-final-high-res.pdf
165. Halpern MT, Ward EM, Pavluck AL, et al: Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: A retrospective analysis. Lancet Oncol 9:222-231, 2008